Skip to main content
. 2019 Dec 16;35(4):677–685. doi: 10.1007/s00467-019-04430-4

Table 2.

Characteristics of patients included in the analyses

All-cause mortality cohort CVD incidence cohort
Characteristics N (%) N (%)
N included 477 381
Sex
Male 264 (55.3) 218 (57.2)
Age at start of RRT (years)
0–<2 30 (6.3) 29 (7.6)
2–<6 50 (10.5) 47 (12.3)
6–<12 113 (23.7) 90 (23.6)
12–<18 284 (59.5) 215 (56.4)
PRD
CAKUT 229 (48.0) 180 (48.6)
GN 80 (16.8) 59 (15.5)
Other 168 (35.2) 137 (36.0)
Initial RRT modality
HD 220 (46.1) 155 (40.7)
PD 207 (43.4) 180 (47.2)
Tx 50 (10.5) 46 (12.1)
RRT modality during follow-up
D + Tx+ 371 (77.8) 289 (75.9)
Pre-Tx 50 (10.5) 46 (12.1)
HD + Tx- 30 (6.3) 24 (6.3)
PD + Tx- 26 (5.5) 22 (5.8)

CVD cardiovascular disease, RRT renal replacement therapy, PRD primary renal disease, CAKUT congenital anomalies of kidney and urinary tract, GN glomerulonephritis, HD haemodialysis, PD peritoneal dialysis, Tx transplanted. PD + Tx started on PD and not transplanted during follow-up, HD + Tx started on HD and not transplanted during follow-up, pre-Tx pre-emptive transplant, D + Tx + started on dialysis (PD or HD) and received a transplant during follow-up